The azithromycin to prevent wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population

Severe respiratory syncytial virus (RSV) bronchiolitis in early life is a significant risk factor for future recurrent wheeze (RW) and asthma. The goal of the Azithromycin to Prevent Wheezing following severe RSV bronchiolitis II (APW-RSV II) clinical trial is to evaluate if azithromycin treatment i...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Contemp Clin Trials Commun
Hlavní autoři: Srinivasan, Mythili, Bacharier, Leonard B., Goss, Charles W., Zhou, Yanjiao, Boomer, Jonathan, Bram, Sarah, Burgdorf, Dana, Burnham, Carey-Ann, Casper, Timothy, Castro, Mario, Coverstone, Andrea, Haslam, Matthew, Kanchongkittiphon, Watcharoot, Kuklinski, Cadence, Lian, Qinghua, Schechtman, Kenneth, Storch, Gregory A., True, Kelly, Wallace, Meghan A., Yin-DeClue, Huiqing, Ahrens, Elizabeth, Wang, Jinli, Beigelman, Avraham
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8219746/
https://ncbi.nlm.nih.gov/pubmed/34189338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2021.100798
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky